Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone: Implications for Treatment of Hypertension and Heart Failure.

Trial Profile

Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone: Implications for Treatment of Hypertension and Heart Failure.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 May 2014

At a glance

  • Drugs Eplerenone (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jan 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Oct 2012 to 1 Oct 2015.
    • 10 Apr 2012 Planned end date changed from 1 Jan 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top